IRIS - Res&Arch Institutional Research Information System - Research & Archive

ANGELI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.650
EU - Europa 1.262
AS - Asia 1.178
SA - Sud America 208
AF - Africa 13
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.319
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.619
SG - Singapore 561
IE - Irlanda 254
UA - Ucraina 214
HK - Hong Kong 196
IT - Italia 189
SE - Svezia 182
BR - Brasile 177
VN - Vietnam 160
CN - Cina 159
RU - Federazione Russa 144
FI - Finlandia 86
DE - Germania 77
GB - Regno Unito 31
KR - Corea 22
CA - Canada 16
FR - Francia 16
TR - Turchia 16
AR - Argentina 13
AT - Austria 13
IN - India 12
CH - Svizzera 10
IQ - Iraq 9
BD - Bangladesh 8
MX - Messico 8
NL - Olanda 8
UZ - Uzbekistan 8
PK - Pakistan 7
PL - Polonia 7
BE - Belgio 6
ZA - Sudafrica 6
EC - Ecuador 5
ID - Indonesia 5
JP - Giappone 5
ES - Italia 4
NZ - Nuova Zelanda 4
VE - Venezuela 4
GR - Grecia 3
LT - Lituania 3
PY - Paraguay 3
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
CL - Cile 2
CZ - Repubblica Ceca 2
EE - Estonia 2
IL - Israele 2
KZ - Kazakistan 2
LB - Libano 2
ME - Montenegro 2
PE - Perù 2
TN - Tunisia 2
UG - Uganda 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
CO - Colombia 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MA - Marocco 1
NR - Nauru 1
RO - Romania 1
RS - Serbia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.319
Salva come PNG Salva come JPEG
Città #
Singapore 371
Chandler 295
Dublin 254
Hong Kong 195
San Mateo 140
Jacksonville 136
Dong Ket 107
Altamura 91
Boardman 90
Ashburn 77
Santa Clara 76
Medford 69
Princeton 69
Lawrence 67
Beijing 57
Wilmington 57
Perugia 48
Moscow 37
Ann Arbor 24
Helsinki 23
New York 23
Seoul 22
Andover 21
Los Angeles 20
São Paulo 18
Ho Chi Minh City 17
Hanoi 16
Saint Petersburg 16
Des Moines 15
Norwalk 11
Izmir 10
Brooklyn 9
Falls Church 9
Munich 9
San Paolo di Civitate 9
Redwood City 8
Shanghai 8
Atlanta 7
Denver 7
Brussels 6
Chennai 6
Chicago 6
Phoenix 6
Rio de Janeiro 6
Rome 6
Woodbridge 6
Amsterdam 5
Belo Horizonte 5
Columbus 5
Council Bluffs 5
Johannesburg 5
London 5
Montreal 5
Porto Alegre 5
Tokyo 5
Toronto 5
Vienna 5
Warsaw 5
Amelia 4
Baghdad 4
Caxias do Sul 4
Mexico City 4
Nuremberg 4
San Francisco 4
Seattle 4
Ankara 3
Bauru 3
Cagliari 3
Falkenstein 3
Goiânia 3
Houston 3
Kaifeng 3
Lahore 3
Manchester 3
Ottawa 3
Piscataway 3
Redmond 3
Ribeirão Preto 3
Salvador 3
San Diego 3
Tashkent 3
Turku 3
Almaty 2
Aracaju 2
Asunción 2
Auckland 2
Bandung 2
Biên Hòa 2
Campos do Jordão 2
Caracas 2
Curitiba 2
Den Haag 2
Dhaka 2
Fortaleza 2
Guayaquil 2
Karachi 2
Lima 2
L’Aquila 2
Manaus 2
Miami 2
Totale 2.755
Salva come PNG Salva come JPEG
Nome #
Beta-blockers and risk of all-cause mortality in non-cardiac surgery. 96
Aliskiren versus ramipril in hypertension. 92
Adverse prognostic significance of new diabetes in treated hypertensive subjects 91
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. 91
New-onset diabetes, antihypertensive treatment, and outcome 89
Above which blood pressure level does the risk of atrial fibrillation increase? 87
Improved cardiovascular risk stratification by a simple ECG index in hypertension 87
Prehypertension and Cardiometabolic Syndrome 86
Angiotensin-converting enzyme inhibitors 84
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications 82
Meta-Analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension 82
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke. 79
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension 77
Angiotensin receptor blockers in hypertension. New insights from Japan. 77
Optimal therapy in hypertensive subjects with diabetes mellitus 77
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain 77
Microalbuminuria and hypertension. 76
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. 76
Betabloccanti e ipertensione arteriosa. Evidence-based medicine o eccessivo accanimento? 76
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients 75
Blood pressure lowering in diabetic patients. 75
Optimizing the definition of dippers and nondippers: is a 70-86% full glass empty? 74
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. 74
Lowering blood pressure with β-blockers in peripheral artery disease: the importance of comorbidity 72
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring. 70
Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. 70
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 70
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. 69
Modernization and hypertension: is the link changing? 69
Quali novità nella gestione dell’ipertensione arteriosa dopo le recenti linee guida europee e nordamericane? 69
Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers. 68
New-onset diabetes in treated hypertensive patients 68
Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention 68
Validation of the A&D UA-774 (UA-767Plus) device for self-measurement of blood pressure. 66
Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement. 65
Risk Prediction Models for Hypertensive Disorders of Pregnancy: Role of 12-Lead Electrocardiography 65
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment. 64
Comparative assessment of angiotensin receptor blockers in different clinical settings. 63
Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes. 62
Finding a place for aliskiren in the wide spectrum of blood pressure lowering agents. 61
"From apennines to andes:" does body mass index affect the relationship between age and blood pressure? 58
Diuretic treatment of hypertension 58
Modern treatment of patients at risk: stilla HOPE for ACE inhibitors? 57
Perioperative beta blockade: the debate continues. 56
Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients. 54
Telmisartan for the reduction of cardiovascular morbidity and mortality. 53
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions. 53
Statins in acute coronary syndrome: very early initiation and benefits. 51
White-coat hypertension in adults. 50
Short- and Long-Term Incidence of Stroke in White-Coat Hypertension 49
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives 48
Multivariable analysis in cerebrovascular research: practical notes for the clinician. 47
Hypertension around the world: new insights from developing countries. 47
Neutrophil count and ambulatory pulse pressure as predictors of cardiovascularadverse events in postmenopausal women with hypertension 47
Good news for beta-blockers in perioperative medicine. 46
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. 46
Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease 45
More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension 44
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome. 44
Hypertension and the J-curve phenomenon: implications for tight blood pressure control 43
Protein intake in type 1 diabetes: putting controversies into perspectives. 43
Mecanismos de la hipertrofia ventricular izquierda en la hipertensión: Más que solo la presión arterial 42
Prognostic value of lipoprotein fractions in essential hypertension. 42
II monitoraggio ambulatoriale della pressione arteriosa nella pratica clinica 41
Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension. 41
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg? 41
Is hydrochlorothiazide more effective on LVH in nonresponders to losartan than in those to atenolol? 40
Tight Blood Pressure Control Saves Lives in Hypertensive Patients With Chronic Kidney Disease 38
Unattended compared to traditional blood pressure measurement in patients with rheumatoid arthritis: a randomised cross-over study 37
Fixed-dose combination therapy in hypertension: cons. 36
Totale 4.416
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.636
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.636
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021311 0 0 0 0 0 35 39 1 54 21 46 115
2021/2022472 9 86 18 35 11 5 1 167 4 3 61 72
2022/2023969 71 218 8 65 89 87 3 62 310 4 37 15
2023/2024325 24 44 17 5 5 1 58 2 38 10 46 75
2024/2025765 4 76 29 51 105 35 50 34 146 42 151 42
2025/2026868 118 115 120 181 236 98 0 0 0 0 0 0
Totale 4.416